VOYA Investment Management’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Buy
17,258
+840
+5% +$18.7K ﹤0.01% 1852
2025
Q4
$353K Buy
16,418
+2,671
+19% +$46.9K ﹤0.01% 1902
2025
Q3
$161K Sell
13,747
-6,466
-32% -$64.3K ﹤0.01% 2224
2025
Q2
$188K Buy
20,213
+1,308
+7% +$10.7K ﹤0.01% 2347
2025
Q1
$127K Buy
18,905
+3,305
+21% +$31.7K ﹤0.01% 2376
2024
Q4
$166K Sell
15,600
-1,439
-8% -$17.4K ﹤0.01% 2443
2024
Q3
$249K Sell
17,039
-356
-2% -$5.06K ﹤0.01% 2363
2024
Q2
$210K Buy
+17,395
New +$272K ﹤0.01% 2438

Other funds holding IMNM

VOYA Investment Management's IMNM Position: Q1 2026 in Review

VOYA Investment Management increased its Immunome (IMNM) stake by 5.1% in Q1 2026, buying an estimated $18.7K and bringing the position to 17,258 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

VOYA Investment Management first reported a position in IMNM in Q2 2024 and has held it in 8 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • VOYA Investment Management held 17,258 shares of Immunome worth $377K as of Q1 2026.
  • VOYA Investment Management bought 840 Immunome shares in Q1 2026, an estimated $18.7K.
  • Immunome made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1852 holding.
  • VOYA Investment Management first reported a position in Immunome in Q2 2024 and has held it in 8 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.